CPLX1 and epilepsy: Future studies may integrate GFAP scoring with detailed gene-level analyses to better understand how specific genes within the 4p16.3 region—such as NSD2 (associated with developmental delay), LETM1 (epilepsy), or CPLX1 (synaptic function)—modulate individual trajectories.